Amy Herr
Fortune : 148 838 $ au 31/05/2026
Fortune : 148 838 $ au 31/05/2026
Amy E.
Herr is the founder of Zephyrus Biosciences, Inc. (2013).
Dr. Herr is an Independent Director at Bio-Techne Corp.
since 2025.
Formerly, Vice President at Chan Zuckerberg Biohub.
Education includes a doctorate from Stanford University and an undergraduate degree from California Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/05/2026 | 2 880 ( 0% ) | 148 838 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIO-TECHNE CORPORATION | Directeur/Membre du Conseil | 01/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Corporate Officer/Principal | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Health Technology |
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national